To include your compound in the COVID-19 Resource Center, submit it here.

Beleodaq belinostat: Phase I data

The open-label, dose-escalation, U.S. Phase I BelCHOP trial in 18 evaluable patients with PTCL showed that IV belinostat plus

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE